{"id":"W3129514033","doi":"10.3389/fonc.2020.569715","title":"nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)","year":2021,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Internal medicine; Docetaxel; Oncology; Clinical endpoint; Paclitaxel; Lung cancer; non-small cell lung cancer (NSCLC); Progression-free survival; Stage (stratigraphy); Chemotherapy; Adverse effect; Cancer; Nivolumab; Immunotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004346595,0.0002345856,0.0006971595,0.0001167128,0.000164061,0.0003385881,0.0002403388,0.0003122262,0.0006175466],"category_scores_gemma":[0.0004619987,0.0001665233,0.0003912443,0.0001811747,0.000167535,0.0002296481,0.0001439474,0.000538743,0.0001681078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006756748,"about_ca_system_score_gemma":0.0006552107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001098186,"about_ca_topic_score_gemma":0.004738244,"domain_scores_codex":[0.9998651,0.00004475213,0.00001305231,0.00002588193,0.00002552917,0.00002561467],"domain_scores_gemma":[0.9998108,0.00003454235,0.00005240548,0.000007185733,0.00000934936,0.00008578478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1831119,0.01150028,0.4245759,0.001169565,0.002187862,0.004316813,0.0005643088,0.004193719,0.0686226,0.0002669728,0.003770056,0.29572],"study_design_scores_gemma":[0.03939836,0.2510854,0.6674369,0.00019643,0.001689278,0.006712438,0.0002454313,0.006204859,0.01061087,0.0002168898,0.01614795,0.00005520805],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971467,0.002044761,0.00005652778,0.00008946371,0.00002515868,0.00005688932,0.00007275838,0.000006397857,0.0005013083],"genre_scores_gemma":[0.9984059,0.0007882504,0.000167263,0.0001524555,0.00002950612,0.0000398565,0.0001637025,0.000001701274,0.0002513259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001098186,"threshold_uncertainty_score":0.004902422,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006197421621776283,"score_gpt":0.3036336720379647,"score_spread":0.2974362504161884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}